Form 8-K - Current report:
SEC Accession No. 0001021771-25-000092
Filing Date
2025-06-13
Accepted
2025-06-13 08:31:05
Documents
16
Period of Report
2025-06-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PRESENTATION - INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH brt8k.htm   iXBRL 8-K 27994
2 PRESS RELEASE DATED JUNE 13, 2025 ex99_1.htm EX-99.1 27605
3 PRESENTATION MATERIALS ex99_2.htm EX-99.2 694
7 image0.jpg GRAPHIC 27025
8 poster.jpg GRAPHIC 11830386
  Complete submission text file 0001021771-25-000092.txt   16513118

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA brtx-20250613.xsd EX-101.SCH 3883
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20250613_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20250613_pre.xml EX-101.PRE 16056
18 EXTRACTED XBRL INSTANCE DOCUMENT brt8k_htm.xml XML 4031
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 251044812
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)